Alpha-1-antitrypsin (AAT) is a protein made by the liver. It protects the lungs from harmful effects of an enzyme named neutrophil elastase. In AAT deficiency, lungs can’t expand and contract well. Breathing is more difficult, and lung damage (emphysema) can result. The signs and symptoms of AAT deficiency commonly present initially in people 20 to 40 years old.
AAT deficiency is inherited, which means parents pass it to children. It’s one of the most common inherited disorders in caucasians. It’s not contagious.
Shortness of breath, being less able to exercise, coughing, sputum production, and wheezing are symptoms. The main manifestation is labored breathing that progressively gets worse. In some babies and children born with this disorder, it may also cause liver damage.
The health care provider may suspect the diagnosis from the medical history and physical examination. X-rays and laboratory tests may be done to rule out similar disorders. A simple blood test that measures AAT will confirm the diagnosis. Chest X-rays and pulmonary function testing can help find out how severe emphysema is. Other blood tests may be done to check the liver function.
Treatment aims to prevent or slow progression of lung disease. Lungs should be protected from infections and inflammation. Immunizations should be given to prevent flu and pneumonia. Health care provider should provide treatment of lung infections at the first sign of infection. Avoid tobacco, smoke, noxious fumes, dust, and pollution. Stay fit by doing regular exercise. In severe cases, your health care provider may recommend replacing the enzyme that’s missing. A specialist in diseases of the lung can help in diagnosing and treatment of this disorder. Medicines such as inhalers may be used to help dilate bronchi (airways in the lung) and decrease lung inflammation. Oxygen and pulmonary rehabilitation programs may also help symptoms. In severe cases, lung surgery and transplantation are other possibilities.
Contact the following source:
Copyright © 2016 by Saunders, an imprint of Elsevier, Inc.
Ferri’s Netter Patient Advisor